Paraneoplastic Syndromes in Neuroendocrine Prostate Cancer: A Systematic Review
Curr Oncol. 2024 Mar 21;31(3):1618-1632. doi: 10.3390/curroncol31030123.ABSTRACTNeuroendocrine prostate cancer (NEPC) is a rare subtype of prostate cancer (PCa) that usually results in poor clinical outcomes and may be accompanied by paraneoplastic syndromes (PNS). NEPC is becoming more frequent. It can initially manifest as PNS, complicating diagnosis. Therefore, we reviewed the literature on the different PNS associated with NEPC. We systematically reviewed English-language articles from January 2017 to September 2023, identifying 17 studies meeting PRISMA guidelines for NEPC and associated PNS. A total of 17 articles we...
Source: Current Oncology - March 27, 2024 Category: Cancer & Oncology Authors: Mohammad Abufaraj Raghad Ramadan Amro Alkhatib Source Type: research
